LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 33.32 | 84.90 | 2643 | 2722 | 0.9708 | 0.9882 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 35.03 | 84.90 | 3011 | 2991 | 1.0066 | 1.0026 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 35.03 | 84.90 | 3092 | 2991 | 1.0337 | 1.0129 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 35.03 | 84.90 | 2763 | 2991 | 0.9237 | 0.9693 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 35.03 | 84.90 | 2852 | 2991 | 0.9534 | 0.9815 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.73 | 84.90 | 3285 | 3254 | 1.0094 | 1.0036 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.73 | 84.90 | 3354 | 3254 | 1.0306 | 1.0115 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.73 | 84.90 | 3015 | 3254 | 0.9265 | 0.9712 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 36.73 | 84.90 | 3076 | 3254 | 0.9452 | 0.9787 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 38.43 | 84.90 | 3510 | 3459 | 1.0146 | 1.0054 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 38.43 | 84.90 | 3595 | 3459 | 1.0391 | 1.0144 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 38.43 | 84.90 | 3278 | 3459 | 0.9475 | 0.9799 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 38.43 | 84.90 | 3342 | 3459 | 0.9660 | 0.9871 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 40.14 | 84.90 | 3744 | 3682 | 1.0168 | 1.0061 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 40.14 | 84.90 | 3814 | 3682 | 1.0358 | 1.0130 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 40.14 | 84.90 | 3562 | 3682 | 0.9674 | 0.9879 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 40.14 | 84.90 | 3617 | 3682 | 0.9823 | 0.9935 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 41.84 | 84.90 | 4016 | 4003 | 1.0032 | 1.0012 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 41.84 | 84.90 | 4094 | 4003 | 1.0227 | 1.0081 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 41.84 | 84.90 | 3914 | 4003 | 0.9777 | 0.9919 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 41.84 | 84.90 | 3959 | 4003 | 0.9890 | 0.9960 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 43.55 | 84.90 | 4273 | 4287 | 0.9965 | 0.9988 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 43.55 | 84.90 | 4350 | 4287 | 1.0145 | 1.0051 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 43.55 | 84.90 | 4172 | 4287 | 0.9730 | 0.9903 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 43.55 | 84.90 | 4226 | 4287 | 0.9856 | 0.9949 | MN20160318_Q02 | H08 |